Gossamer Bio Inc. (GOSS)
NASDAQ: GOSS
· Real-Time Price · USD
1.04
0.03 (2.97%)
At close: May 15, 2025, 3:59 PM
1.02
-1.92%
After-hours: May 15, 2025, 04:12 PM EDT
2.97% (1D)
| Bid | 1.01 |
| Market Cap | 236.31M |
| Revenue (ttm) | 114.7M |
| Net Income (ttm) | -56.53M |
| EPS (ttm) | -0.25 |
| PE Ratio (ttm) | -4.16 |
| Forward PE | -2.47 |
| Analyst | Buy |
| Ask | 1.09 |
| Volume | 1,597,650 |
| Avg. Volume (20D) | 1,614,481 |
| Open | 1.00 |
| Previous Close | 1.01 |
| Day's Range | 0.99 - 1.07 |
| 52-Week Range | 0.50 - 1.55 |
| Beta | 1.82 |
About GOSS
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol GOSS
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for GOSS stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsEarnings Surprise
Gossamer Bio has released their quartely earnings
on May 15, 2025:
Next Earnings Release
Gossamer Bio Inc. is scheduled to release its earnings on May 15, 2025,
after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
10 months ago
+22.26%
Gossamer Bio shares are trading higher after Oppen...
Unlock content with
Pro Subscription
11 months ago
+0.02%
Gossamer Bio shares are trading higher after competitor Aerovate Therapeutics reported topline results from the Phase 2b portion of IMPAHCT trial of AV-101 for pulmonary arterial hypertension.
